Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008098

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008098

IVD Raw Materials Market, By Product, By Technology, By End-User, By Geography

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

IVD Raw Materials Market is estimated to be valued at USD 34,281.6 Mn in 2026 and is expected to reach USD 50,790.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 34,281.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.80% 2033 Value Projection: USD 50,790.6 Mn

In vitro diagnostics can detect diseases/conditions, and can be used to monitor overall health to help cure, treat, and/or prevent diseases. In vitro diagnostics are utilized to diagnose a wide range of medical disorders, such as cardiovascular disease, cancer, diabetes, infectious disease, nephrology, autoimmune diseases, and HIV/AIDS. IVD are tests done on the blood sample or tissue sample that have been taken from the human body. In short, IVD raw materials used to determine the status of a person's health. The core raw materials of in vitro diagnostic (IVD) reagents/kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents/kits.

Market Dynamics

The outbreak of COVID-19, high prevalence of chronic diseases, advanced technologies in in vitro diagnostic products, rise in use of point-of-care diagnostics, rising geriatric population, and growing significance of companion diagnostics are some major factors expected to boost the growth of the global IVD raw materials market during the forecast period.

In August 2021, Roche received the U.S. Food and Drug Administration (FDA) approval for VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Moreover, in May 2020, ERBA Diagnostics Mannheim GmbH announced the launch of its immunoassay-based kit, ErbaLisa COVID-19 ELISA kits, for the detection of IgG and IgM antibodies to SARS-CoV-2. In March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test, for the diagnosis of COVID-19, and BioMedomics launched a point-of-care COVID-19 test that can detect antibodies in blood within 15 minutes.

Key features of the study

  • This report provides in-depth analysis of the global IVD raw materials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global IVD raw materials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KgaA, F. Hoffmann-La Roche, Thermo Fisher Scientific, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global IVD raw materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global IVD raw materials market.

Market Segmentation

  • Global IVD Raw Materials Market, By Product
    • Antibodies & Antigens
    • Enzymes
    • Proteins
    • Biological Buffers
    • Others
  • Global IVD Raw Materials Market, By Technology
    • Clinical Chemistry
    • Immunochemistry
    • Molecular diagnostics
    • Others
  • Global IVD Raw Materials Market, By End-User
    • Pharma, Biotech & MedTech Companies
    • Diagnostic Laboratories
    • Others
  • Global IVD Raw Materials Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global IVD Raw Materials Market: Key Players
    • Aalto Bio Reagents
    • Fapon Biotech
    • Fujirebio
    • Merck KgaA
    • Hoffmann-La Roche
    • Thermo Fisher Scientific
Product Code: CMI5234

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global IVD Raw Materials Market, By Product, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Antibodies & Antigens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Biological Buffers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global IVD Raw Materials Market, Technology, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Clinical Chemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Immunochemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Molecular diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global IVD Raw Materials Market, By End User, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Pharma, Biotech & MedTech Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global IVD Raw Materials Market, By Geography, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • South Africa
  • Central Africa
  • North Africa
  • Rest of World

8. Competitive Landscape

  • Aalto Bio Reagents
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fapon Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujirebio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KgaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!